tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KNSA Stock Latest News

Strong Commercial Execution and Growth Potential Drive Buy Rating for Kiniksa Pharmaceuticals
RatingsStrong Commercial Execution and Growth Potential Drive Buy Rating for Kiniksa Pharmaceuticals
2d ago
KNSA
Kiniksa announces Orphan Drug Designation for KPL-387
PremiumThe Fly
Kiniksa announces Orphan Drug Designation for KPL-387
7d ago
KNSA
Kiniksa price target raised to $50 from $45 at Citi
PremiumThe Fly
Kiniksa price target raised to $50 from $45 at Citi
7d ago
KNSA
Kiniksa granted orphan designation for treatment of pericarditis
PremiumThe Fly
Kiniksa granted orphan designation for treatment of pericarditis
7d ago
KNSA
Kiniksa price target raised to $44 from $38 at Wedbush
PremiumThe Fly
Kiniksa price target raised to $44 from $38 at Wedbush
11d ago
KNSA
Kiniksa Pharmaceuticals: Strong Buy Rating Driven by Arcalyst’s Market Success and Promising Pipeline
PremiumRatingsKiniksa Pharmaceuticals: Strong Buy Rating Driven by Arcalyst’s Market Success and Promising Pipeline
25d ago
KNSA
Kiniksa initiated with a Buy at TD Cowen
Premium
The Fly
Kiniksa initiated with a Buy at TD Cowen
25d ago
KNSA
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth
Premium
Company Announcements
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth
2M ago
8K
KNSA
Kiniksa Pharmaceuticals Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Kiniksa Pharmaceuticals Reports Strong Q2 2025 Growth
3M ago
KNSA
Kiniksa Pharmaceuticals Reports Strong ARCALYST Growth
PremiumCompany Announcements
Kiniksa Pharmaceuticals Reports Strong ARCALYST Growth
3M ago
KNSA
Kiniksa price target raised to $54 from $45 at Jefferies
PremiumThe Fly
Kiniksa price target raised to $54 from $45 at Jefferies
3M ago
KNSA
Kiniksa reports Q2 EPS 23c, consensus 26c
PremiumThe Fly
Kiniksa reports Q2 EPS 23c, consensus 26c
3M ago
KNSA
Kiniksa raises FY25 ARCALYST revenue view to $625M-$640M from $590M-$605M
PremiumThe FlyKiniksa raises FY25 ARCALYST revenue view to $625M-$640M from $590M-$605M
3M ago
KNSA
KNSA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KNSA Earnings this Week: How Will it Perform?
3M ago
KNSA
Kiniksa price target raised to $42 from $30 at Wells Fargo
Premium
The Fly
Kiniksa price target raised to $42 from $30 at Wells Fargo
4M ago
KNSA
Kiniksa Pharmaceuticals Unveils Phase 2/3 Trial Plans
PremiumCompany Announcements
Kiniksa Pharmaceuticals Unveils Phase 2/3 Trial Plans
5M ago
8K
KNSA
Kiniksa announces details for planned 2/3 trial of KPL-387
PremiumThe Fly
Kiniksa announces details for planned 2/3 trial of KPL-387
5M ago
KNSA
Kiniksa Pharmaceuticals Annual Shareholders Meeting Decisions
PremiumCompany Announcements
Kiniksa Pharmaceuticals Annual Shareholders Meeting Decisions
5M ago
8K
KNSA
Kiniksa Pharmaceuticals Q1 2025 Earnings: Strong Growth
PremiumCompany Announcements
Kiniksa Pharmaceuticals Q1 2025 Earnings: Strong Growth
6M ago
KNSA
Kiniksa announces Carly Pearce joined the Life DisRPted Campaign
PremiumThe FlyKiniksa announces Carly Pearce joined the Life DisRPted Campaign
6M ago
KNSA
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Q1 2025 Growth
6M ago
KNSA
Kiniksa price target raised to $45 from $40 at Jefferies
Premium
The Fly
Kiniksa price target raised to $45 from $40 at Jefferies
6M ago
KNSA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >